Medicaid utilization in children: Condition-specific incidence and spending - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Condition-Specific Incidence and Spending Among Children Using Medicaid

  • By

  • Madelyn Hall

  • Jay G. Berry

  • Samir S. Shah

  • Vineeta Mittal

  • Matt Hall

  • Henry T. Puls

  • Jessica L. Markham

  • October 7, 2026

Share

Clinical Report: Condition-Specific Incidence and Spending Among Children Using Medicaid

Overview

This retrospective analysis examined healthcare utilization and spending among 7.2 million children enrolled in Medicaid across 12 states in 2022. The supplied results report that 78.5% had at least one recorded claim and 21.5% had none; the excerpt does not provide condition-specific incidence or spending results.

Background

Medicaid covers about 37 million children in the United States and accounts for a substantial share of state and national healthcare spending. Preventive services, including well-child examinations, immunizations, and developmental and behavioral screenings, are described in the source as reducing reliance on higher-cost acute care. The article notes that limited prior research has characterized Medicaid expenditures by clinical condition and care setting. It therefore examines utilization and spending across preventive care, chronic conditions, nonchronic conditions, and service settings.

Data Highlights

MeasureFinding
Study population7.2 million children younger than 20 years enrolled in Medicaid across 12 states in 2022
Mean age10.4 years (SD, 6.3)
Non-Hispanic White enrollees43.2%
Mean enrollment duration295 days (SD, 98.0)
Capitated plan enrollment57.8%
At least one recorded Medicaid claim78.5%
No recorded Medicaid claims21.5%

Key Findings

  • The retrospective analysis used the 2022 Medicaid Marketscan database and included children younger than 20 years enrolled for any length of time across 12 states.
  • Children had a mean age of 10.4 years (SD, 6.3), and mean enrollment duration was 295 days (SD, 98.0).
  • Capitated plans covered 57.8% of the study population.
  • At least one Medicaid claim was recorded for 78.5% of children; 21.5% were classified as nonutilizers because they had no claims.
  • Claims were categorized as preventive care, care for chronic conditions, or care for nonchronic conditions using PECCS categories and specified spending thresholds.
  • The supplied article excerpt does not include the subsequent results on condition-specific incidence, care-setting distribution, or spending.

Clinical Implications

The study’s stated aim was to characterize pediatric Medicaid utilization and spending across preventive, chronic, and nonchronic care and across care settings. The supplied results are insufficient to identify which conditions or settings accounted for the greatest incidence or spending.

Conclusion

The study describes a large, multistate Medicaid cohort and reports that more than one in five enrolled children had no recorded claim in 2022. The available excerpt does not provide the condition-specific spending findings needed to summarize the distribution of costs.

Related Resources & Content

  1. Article excerpt, Source and year not provided -- Condition-Specific Incidence and Spending Among Children Using Medicaid
  2. Centers for Medicare & Medicaid Services, Medicaid -- EPSDT Guidance, year not specified
  3. MACPAC, Report to Congress on Medicaid and CHIP, 2026 -- Behavioral Health in Medicaid and the State Children’s Health Insurance Program
  4. JAMA Network Open — Projected Oral Health Outcomes and Costs Associated With Pediatric Medicaid Disenrollment
  5. American Journal of Epidemiology — Mental Health in Children Experiencing Homelessness: Insights from Medicaid Data in New York City’s Shelter System
  6. ASCO Publications — Assessing the impact of early Medicaid expansion on insurance rates among children with cancer.
  7. ASCO Publications — Assessing the impact of early Medicaid expansion on insurance rates among children with cancer.
  8. EPSDT Guidance | Medicaid
  9. Report to Congress on Medicaid and CHIP March 2026
  10. EPSDT Guidance | Medicaid
  11. Report to Congress on Medicaid and CHIP March 2026
  12. Effectiveness and Impact of Maternal RSV Immunization and Nirsevimab on Medically Attended RSV in US Children - PubMed

Original Source(s)

Related Content